Targeting Social Function in Anxiety and Eating Disorders
This study is looking at two different ways to help people with eating disorders and anxiety by focusing on how they interact with others. One approach uses educational presentations about brain function and social processing, while the other involves interactive art therapy tasks followed by education. The goal is to see if these interventions can improve eating disorder symptoms. You might be able to join if you are between 18 and 30 years old and have been diagnosed with an eating disorder (like Anorexia Nervosa or Bulimia Nervosa) or an anxiety disorder in the past year. Researchers will measure changes in your eating disorder symptoms over 12 months to see if the interventions are helpful.
- Study design
- This study is interventional and plans to enroll 60 participants. It compares two behavioral interventions: an educational series and an interactive art therapy series.
- What's involved
- You will attend a baseline visit, complete questionnaires, and participate in eight treatment sessions over 12 weeks. You will also complete three virtual follow-up assessments.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your eating disorder symptoms will be measured at four, eight, and twelve months after the start of the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Targeting Social Function in Anxiety and Eating Disorders
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Carrie J McAdams, MD PhD · PRINCIPAL_INVESTIGATOR · University of Texas Southwestern Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in eating disorder symptomspre-intervention (T0) to four months from start of intervention (T4)
The Eating Disorder Examination Questionnaire (EDE-Q) measures the severity of eating disorder symptoms. Possible scores on global eating disorder pathology range from 0 to 6, with higher scores indicating greater severity. Scores of 2 or less are considered typical of normative eating behavior/cognitions, while scores of 3-6 suggest the presence of clinically significant eating disorder symptoms.
- Change in eating disorder symptomsfour months from start of intervention (T4) to eight months from start of intervention (T8)
The Eating Disorder Examination Questionnaire (EDE-Q) measures the severity of eating disorder symptoms. Possible scores on global eating disorder pathology range from 0 to 6, with higher scores indicating greater severity. Scores of 2 or less are considered typical of normative eating behavior/cognitions, while scores of 3-6 suggest the presence of clinically significant eating disorder symptoms.
- Change in eating disorder symptomseight months from start of intervention (T8) to twelve months from start of intervention (T12)
The Eating Disorder Examination Questionnaire (EDE-Q) measures the severity of eating disorder symptoms. Possible scores on global eating disorder pathology range from 0 to 6, with higher scores indicating greater severity. Scores of 2 or less are considered typical of normative eating behavior/cognitions, while scores of 3-6 suggest the presence of clinically significant eating disorder symptoms.
- Change in eating disorder symptomspre-intervention (T0) to twelve months from start of intervention (T12)
The Eating Disorder Examination Questionnaire (EDE-Q) measures the severity of eating disorder symptoms. Possible scores on global eating disorder pathology range from 0 to 6, with higher scores indicating greater severity. Scores of 2 or less are considered typical of normative eating behavior/cognitions, while scores of 3-6 suggest the presence of clinically significant eating disorder symptoms.
- Change in depression symptomspre-intervention (T0) to four months from start of intervention (T4)
The Patient Health Questionnaire (PHQ-9) is a 9-item measure of depression symptoms. Each item is rated on a four-point scale (0 = not at all; 1 = several days; 2 = more than half the days; 3 = nearly every day). Possible scores range from 0-27, allowing depression to be categorized as minimal (1-4), mild (5-9), moderate (10-14), moderately severe (15-19), or severe (20-27).
- Change in depression symptomsfour months from start of intervention (T4) to eight months from start of intervention (T8)
The Patient Health Questionnaire (PHQ-9) is a 9-item measure of depression symptoms. Each item is rated on a four-point scale (0 = not at all; 1 = several days; 2 = more than half the days; 3 = nearly every day). Possible scores range from 0-27, allowing depression to be categorized as minimal (1-4), mild (5-9), moderate (10-14), moderately severe (15-19), or severe (20-27).
- Change in depression symptomseight months from start of intervention (T8) to twelve months from start of intervention (T12)
The Patient Health Questionnaire (PHQ-9) is a 9-item measure of depression symptoms. Each item is rated on a four-point scale (0 = not at all; 1 = several days; 2 = more than half the days; 3 = nearly every day). Possible scores range from 0-27, allowing depression to be categorized as minimal (1-4), mild (5-9), moderate (10-14), moderately severe (15-19), or severe (20-27).
- Change in depression symptomspre-intervention (T0) to twelve months from start of intervention (T12)
The Patient Health Questionnaire (PHQ-9) is a 9-item measure of depression symptoms. Each item is rated on a four-point scale (0 = not at all; 1 = several days; 2 = more than half the days; 3 = nearly every day). Possible scores range from 0-27, allowing depression to be categorized as minimal (1-4), mild (5-9), moderate (10-14), moderately severe (15-19), or severe (20-27).
- Change in anxiety symptomspre-intervention (T0) to four months from start of intervention (T4)
The General Anxiety Disorder Scale (GAD-7) is a 7-item measure of anxiety symptoms. Each item is rated on a four-point scale (0 = not at all, 1 = several days, 2 = more than half the days, and 3 = nearly every day). Possible scores range from 0-21, allowing anxiety to be classified as minimal (0-4), mild (5-9), moderate (10-14), or severe (15-21).
- Change in anxiety symptomsfour months from start of intervention (T4) to eight months from start of intervention (T8)
The General Anxiety Disorder Scale (GAD-7) is a 7-item measure of anxiety symptoms. Each item is rated on a four-point scale (0 = not at all, 1 = several days, 2 = more than half the days, and 3 = nearly every day). Possible scores range from 0-21, allowing anxiety to be classified as minimal (0-4), mild (5-9), moderate (10-14), or severe (15-21).
- Change in anxiety symptomseight months from start of intervention (T8) to twelve months from start of intervention (T12)
The General Anxiety Disorder Scale (GAD-7) is a 7-item measure of anxiety symptoms. Each item is rated on a four-point scale (0 = not at all, 1 = several days, 2 = more than half the days, and 3 = nearly every day). Possible scores range from 0-21, allowing anxiety to be classified as minimal (0-4), mild (5-9), moderate (10-14), or severe (15-21).
- Change in anxiety symptomspre-intervention (T0) to twelve months from start of intervention (T12)
The General Anxiety Disorder Scale (GAD-7) is a 7-item measure of anxiety symptoms. Each item is rated on a four-point scale (0 = not at all, 1 = several days, 2 = more than half the days, and 3 = nearly every day). Possible scores range from 0-21, allowing anxiety to be classified as minimal (0-4), mild (5-9), moderate (10-14), or severe (15-21).
- Change in overall levels of psychopathologypre-intervention (T0) and at the last post-intervention follow-up (T12)
The DSM-5 Cross-Cutting Symptom Measure (DSM-XC) is a 23-item measure of overall levels of psychopathology across 13 psychiatric domains. Each item on the measure is rated on a 5-point scale (0=none or not at all; 1=slight or rare, less than a day or two; 2=mild or several days; 3=moderate or more than half the days; and 4=severe or nearly every day). The score on each item within a domain should be reviewed. Because additional inquiry is based on the highest score on any item within a domain, the clinician is asked to indicate that score in the "Highest Domain Score" column
- Change in eating disorder diagnosisbaseline and final study visits (approximately 1 year apart)
The Eating Disorder Diagnostic Assessment for DSM-5 (EDA-5) is a semi-structured clinical interview meant to assist in the assessment of a feeding or eating disorder according to DSM-5 criteria.